- Home
- NBTX vs EMF Comparison
NBTX vs EMF Comparison
Compare NBTX & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- EMF
- Stock Information
- Founded
- NBTX 2003
- EMF 1987
- Country
- NBTX France
- EMF United States
- Employees
- NBTX N/A
- EMF N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- EMF Finance/Investors Services
- Sector
- NBTX Health Care
- EMF Finance
- Exchange
- NBTX Nasdaq
- EMF Nasdaq
- Market Cap
- NBTX 178.7M
- EMF 180.1M
- IPO Year
- NBTX 2020
- EMF N/A
- Fundamental
- Price
- NBTX $3.29
- EMF $12.18
- Analyst Decision
- NBTX Strong Buy
- EMF
- Analyst Count
- NBTX 1
- EMF 0
- Target Price
- NBTX $8.00
- EMF N/A
- AVG Volume (30 Days)
- NBTX 11.4K
- EMF 29.3K
- Earning Date
- NBTX 04-02-2025
- EMF 01-01-0001
- Dividend Yield
- NBTX N/A
- EMF 6.16%
- EPS Growth
- NBTX N/A
- EMF N/A
- EPS
- NBTX N/A
- EMF N/A
- Revenue
- NBTX N/A
- EMF N/A
- Revenue This Year
- NBTX N/A
- EMF N/A
- Revenue Next Year
- NBTX $277.81
- EMF N/A
- P/E Ratio
- NBTX N/A
- EMF N/A
- Revenue Growth
- NBTX N/A
- EMF N/A
- 52 Week Low
- NBTX $2.76
- EMF $10.58
- 52 Week High
- NBTX $7.51
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- NBTX 46.34
- EMF 44.78
- Support Level
- NBTX $3.28
- EMF $12.04
- Resistance Level
- NBTX $3.53
- EMF $12.37
- Average True Range (ATR)
- NBTX 0.18
- EMF 0.29
- MACD
- NBTX 0.00
- EMF -0.01
- Stochastic Oscillator
- NBTX 46.48
- EMF 56.22
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.